Commercial leadership across four practice areas
PharmaKonsult partners with biotechnology CEOs and boards on the commercial decisions that define company value—from culture and leadership through launch, rare disease, and therapeutic specialization.
Strategic Drug Development & Commercialization Advisory
Strategic advisory across biotechnology drug development and commercialization—helping leadership make the decisions that increase regulatory success, adoption, partnerships and long-term value.
We help companies integrate commercialization into development: market reality, access strategy, physician confidence, and the leadership decisions that determine launch performance.
Commercial Leadership, Culture & Organizational Performance
High-performing commercial organizations are built through exceptional leadership, disciplined execution, and a culture of trust and accountability.
We help biotechnology companies recruit and develop leaders, optimize commercial organizations, and build cultures that sustain long-term performance.
Specialty Neurology
Commercial and development strategy across specialty neurology—from epilepsy and rare neurological disorders to broader CNS opportunities.
We help companies evaluate clinical evidence, market potential, competitive positioning, access, partnering and commercialization.
Rare Disease Commercialization
Rare disease markets require a different commercial model.
We help biotechnology companies understand patient identification, Centers of Excellence, specialist networks, market access, patient services and the commercial infrastructure required to translate innovation into commercial success.
How PharmaKonsult works
Every engagement is grounded in more than thirty years of commercial leadership—not theoretical consulting. We work alongside CEOs, boards, and commercial leaders to strengthen the decisions that shape organizational performance and long-term market success.
Whether you are building a commercial organization for the first time, preparing for launch, or refining performance in a specialized therapeutic area, our approach is practical, experience-based, and tailored to the realities of biotechnology commercialization.
Who we help
We partner with biotechnology companies preparing for commercialization, launching innovative therapies, or strengthening commercial performance—particularly in rare disease and specialty neurology.
- CEOs and boards seeking commercial clarity before and through launch
- Leadership teams building or restructuring commercial organizations
- Companies navigating specialty and rare disease market complexity
- Organizations that need experienced judgment alongside strategy
Start with the right conversation
Explore a practice area above, or reach out directly to discuss where commercial leadership can create the greatest impact for your organization.
